Radiation absorbed dose estimates for [1-carbon-11]-glucose in adults: The effects of hyperinsulinemia

Journal of Nuclear Medicine

Volumn 37, Issue 10, 1996, Pages 1668-1672

  Powers, William J ^a,b  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

absorbed dose; PET; 1 11C glucose

Indexed keywords

CARBON 11; GLUCOSE;

ADULT; ARTICLE; DOSE CALCULATION; DOSIMETRY; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; ISOTOPE LABELING; NORMAL HUMAN; PRIORITY JOURNAL; RADIATION DOSE; TISSUE DISTRIBUTION;

EID: 0029846396     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
2. Huang S-C, Phelps ME, Hoffman EJ, et al. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-E82.
3. 18F]Fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979;44:127-137.
4. 11C]glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects. J Cereb Blood Flow Metab 1982;2:307-319.
5. Crane PD, Pardridge WM, Braun LD, et al. The interaction of transport and metabolism on brain glucose utilization: a reevaluation of the lumped constant. J Neurochem 1981;369:1601-1604.
6. Gjedde A, Diemer NH. Double-tracer study of the fine regional blood-brain glucose transfer in rat by computer-assisted autoradiography. J Cereb Blood Flow Metab 1985;5:282-289.
7. Gjedde A. Does deoxyglucose uptake in the brain reflect energy metabolism? Biochem Pharm 1987;36:1853-1861.
8. 14C]deoxyglucose technique. J Cereb Blood Flow Metab 1992;12:70-77.
9. Suda S, Shinohara M, Miyaoka M, et al. The lumped constant of the deoxyglucose method in hypoglycemia: effects of moderate hypoglycemia in local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 1990;10:499-509.
10. Dienel GA, Cruz NF, Kentaro M, et al. Direct measurements of the λ of the lumped constant of the deoxyglucose method in the rat brain: determination of λ and lumped constant from tissue glucose concentration or equilibrium brain/plasma distribution for methylglucose. J Cereb Blood Flow Metab 1991;11:25-34.
11. Blomqvist G, Gjedde A, Gutniak M, et al. Facilitated transport of glucose from blood to brain in man and the effect of moderate hypoglycemia in cerebral glucose utilization. Eur J Nucl Med 1991;18:834-837.
12. 11C] glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am J Physiol 1990;258:E805-E812.
13. Lifton JF, Welch MJ. Preparation of glucose labeled with 20-min half-lived carbon-11. Radiation Res 1971;45:35-40.
14. 11C-glucose. J Cereb Blood Flow Metab 1985;5:S623-S624.
15. Sacks W. Cerebral metabolism of doubly labeled glucose in humans in vivo. J Appl Physiol 1965;20:117-130.
16. 11C]D-glucose. J Cereb Blood Flow Metab 1990;10:467-483.
17. O'Sullivan F, Muzi M, Spence A, Graham MM. An improved analysis technique for dual tracer PET studies with particular application to lumped constant imaging [Abstract]. J Nucl Med 1992;33:944.
18. 11C-D-glucose during stepped hypoglycemia. Ann Neurol 1995;38:599-609.
19. Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations, rev. ed. New York, NY: Society of Nuclear Medicine; 1991.
20. Weber DA, Eckerman KF, Dillman LT, Ryman JC. MIRD:radionuclide data and decay schemes. New York, NY: Society of Nuclear Medicine; 1989.
21. Pitts RF. Kidney and body fluids, an introductory text, 2nd Ed. Chicago, IL: Year Book Medical Publishers Inc.;1968, 73-75.
22. 14C-labeled glucose in man and an estimation of the extent of glucose metabolism by the hexose monophosphate pathway. J Clin Invest 1961;40:1263-1279.
23. 15O) in newborn infants. J Nucl Med 1988;29:1961-1970.
24. Comroe JH. Physiology of respiration. Chicago, IL: Year Book Medical Publishers; 1965:17-27.
25. Ferrannini E, Smith JD, Cobelli C, et al. Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest 1985;76:357-364.
26. Ikkos D, Luft R. On the intravenous glucose tolerance test. Acta Endocrin 1957;25: 312-334.
27. Andreoli TE. Disorders of fluid volume, electrolyte and acid-base balance. In: JB Wyngaarden and LH Smith, Jr., eds. Textbook of medicine, 18th ed. Philadelphia, PA: WB Saunders Co.;1988;529-558.
28. deFronzo RA. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-687.
29. Baron AD, Brechtel G, Wallace P, Edelman SV. Rates and tissue sites of non-insulin and insulin-mediated glucose uptake in humans. Am J Physiol 1988;255:E769-E774.
30. Knuuti MJ, Nuutila P, Ruotsalainen U, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992;33:1255-1262.
31. Hicks RJ, vom Dahl J, Lee KS, et al. Insulin-glucose clamp for standardization of metabolic conditions during F-18 fluoro-deoxyglucose PET imaging [Abstract]. J Am Coll Cardiol 1991;17:381A.
32. Christy M. Mathematical phantoms representing children of various age for use in estimates of internal dose. Oak Ridge National Laboratory report. ORNL/TM-8381/V6. Springfield, VA: National Technical Information Service U.S. Department of Commerce; 1980.
33. Cloutier RJ, Watson EE. Radiation dose from radionuclides in the blood. In: Cloutier RJ, Edwards CL, Snyder WS, Anderson EB, eds. Medical radionuclides: radiation dose and effects. Oak Ridge, TN: AEC Symposium Series 20, Conf-691212;1970: 325-346.
34. Snyder WS, Cook MJ, Nasset ES, et al. Report of the task group on reference man (ICRP No. 23). New York: Pergamon Press;1974.
35. Mejia AA, Nakamura T, Masatoshi I, et al. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med 1991;32:699-706.
36. Holliday MA. Metabolic rate and organ size during growth from infancy to maturity and during late gestation and early infancy. Pediatrics 1971;47:169-179.
37. Loevinger R, Japha EM, Brownell GL. Discrete radioisotope sources. In: Hine GJ, Brownell GL, eds. Radiation dosimetry. New York: Academic Press;1956:693-799.
38. Herscovitch P, Raichle ME. What is the correct value for the brain-blood partition coefficient for water? J Cereb Blood Flow Metab 1985;5:65-69.
39. Cristy M, Eckerman K. Specific absorbed fractions of energy at various ages from internal photons sources. ORNL/TM-8381 V1-V7 Oak Ridge National Laboratory, Oak Ridge, TN;1987.
40. Stabin M. MIRDOSE 3 Radiation Internal Dose Information Center, Oak Ridge Institute for Science and Education, Oak Ridge, TN, 1994.
41. Eckerman KF, Christy M, Warner GG. Dosimetric evaluation of brain scanning agents. In: Watson EE, Schlafke-Stelson AT, Coffey JL, Cloutier RJ, eds. Third International Radiopharmaceutical Dosimetry Symposium HHS Publication FDA 81-8166, Rockville, MD: FDA;1981:527-540.
42. Jones SC, Alavi A, Christman D, et al. The radiation dosimetry of 2-[F-18]Fluoro-2-deoxy-D-glucose in man. J Nucl Med 1982;23:613-617.
43. Huda W, McLellan J, McLellan Y. How will the new definition of 'effective dose' modify estimates of dose in diagnostic radiology? J Radiology Prot 1991;11:241-247.